‚Sleep hygiene‘ should be integrated into epilepsy diagnosis and management

 

Children with epilepsy sleep poorly compared to healthy children, and are more likely to experience disruptions such as night terrors, sleep walking or sleep disordered breathing, according to a new study.

A team at the University of Birmingham’s Centre for Human Brain Health analysed 19 published studies on sleep and epilepsy in children and adolescents to try to better understand and articulate the links between them.

Their findings, published in Sleep Medicine Reviews, highlight the significantly poorer sleep experienced by children and adolescents with epilepsy, and present a strong argument for screening children for sleep problems as an integral part of diagnosis and management of the condition.

Lead author Alice Winsor explains: „We know that sleep and epilepsy have a bidirectional relationship: epilepsy has an impact on sleep, because of seizures waking children up in the night, for example. At the same time, disrupted sleep can increase the likelihood of seizures. Despite the available research, however, sleep is not routinely evaluated by clinicians during the diagnosis and care of this condition.

„In typically developing children, it’s well known that the effects of inadequate sleep have a wide impact on behaviour and mental health and this affects not just them, but the wider family as well. In children with epilepsy these effects are more complicated, but also more likely to be overlooked, because of the clinical focus on the epilepsy. Our research draws together the available evidence to make a compelling case for sleep assessments to be included in epilepsy management.“

In their detailed literature analysis, the researchers found children with epilepsy slept, on average, 34 minutes less per night than those without epilepsy and had significantly more episodes of night waking or parasomnias – including night terrors and sleep walking. They also had poorer sleep quality and a higher percentage of light sleep than healthy children. These were evident in the literature via both objective measurements such as wearing a sleep tracking watch, and subjective evidence supplied via patient and carer questionnaires.

„Epilepsy is a chronic and unpredictable disease and the association with sleep disruption only further negatively impacts quality of life for the child and the family,“ Alice adds. „Addressing sleep problems and sleep hygiene at an early stage in treatment could reduce the impact of the disease, and also reduce the likelihood of a sleep problem progressing to a sleep disorder, with serious and long term health implications.“

The researchers also found that children with drug-resistant epilepsy appeared most vulnerable to sleep disturbances, although more research is necessary into whether this is caused by medication or by recurrent seizures.

 

The research was funded by the Waterloo Foundation.

 

Notes to editor

  • The University of Birmingham is ranked amongst the world’s top 100 institutions. Its work brings people from across the world to Birmingham, including researchers, teachers and more than 6,500 international students from over 150 countries.

 

 


University of Birmingham, 10.02.2021 (tB).

Schlagwörter: , ,

MEDICAL NEWS

COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…
Suliqua®: In komplexem Umfeld – einfach besser eingestellt
Suliqua®: Überlegene HbA1c-Senkung  im Vergleich zu Mischinsulinanalogon
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 

ERNÄHRUNG

Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen

ONKOLOGIE

Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
WHO veröffentlicht erste Klassifikation von Tumoren im Kindesalter
Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!

MULTIPLE SKLEROSE

Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…
Stellungnahme zur 3. Impfung gegen SARS-CoV2 bei Personen mit MS
NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…